secwatch.observer — SEC 8-K summary
======================================

Issuer:     PURE BIOSCIENCE, INC. (PURE)
CIK:        0001006028
Form:       8-K
Filed at:   2026-06-15T20:05:40+00:00
Accession:  0001493152-26-028686
Event type: earnings
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PURE Bioscience reports Q3 net loss of $624k; CEO Bartlett to retire July 31, Kitchell to succeed
--------------------------------------------------------------------------------

- Q3 net product sales $506k (+3.5% YoY); net loss $624k vs $580k YoY; EPS ($0.01).
- Nine-month net product sales $1.66M (+15.4% YoY); net loss $1.87M vs $2.07M YoY.
- CEO Robert Bartlett retiring July 31, 2026; President Jeff Kitchell appointed CEO effective Aug 1.
- Director Bernard Blotner leaving board due to health; no replacement named.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006028/000149315226028686/0001493152-26-028686-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006028/000149315226028686/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-028686

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer